The abstract is read at the publisher; the summary is JClub's.
KDIGO’s 2026 anemia guideline for chronic kidney disease updates diagnosis and treatment, including an ESA maintenance hemoglobin target below 11.5 g/dL (<115 g/L).
- Why it matters: Clinicians need an evidence-graded, internationally developed approach to manage CKD anemia, balancing iron therapy, ESA/HIF-PHI use, and transfusion decisions.
- What they did: An international work group defined scope, an independent team reviewed evidence through October 2024 using GRADE, and a public stakeholder review informed the final 8 graded recommendations plus 49 practice points.
- The result: Recommendations link iron therapy to transferrin saturation and ferritin thresholds, prefer intravenous iron in hemodialysis, favor ESA over HIF-PHI first-line, and set individualized ESA initiation and a maintenance Hb ceiling below 11.5 g/dL (<115 g/L).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.